TEM
NASDAQ · Life Sciences Tools & Services
Tempus Ai Inc
$78.03
+0.19 (+0.24%)
Financial Highlights (FY 2026)
Revenue
1.32B
Net Income
-253,709,321
Gross Margin
62.7%
Profit Margin
-19.3%
Rev Growth
+58.3%
D/E Ratio
2.52
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 62.7% | 62.7% | 44.0% | 44.0% |
| Operating Margin | -20.8% | -18.7% | 20.9% | 23.7% |
| Profit Margin | -19.3% | -18.3% | 17.8% | 17.2% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 1.32B | 831.91M | 4.22B | 4.70B |
| Gross Profit | 826.18M | 521.94M | 1.85B | 2.07B |
| Operating Income | -274,295,886 | -155,958,239 | 880.21M | 1.12B |
| Net Income | -253,709,321 | -144,253,199 | 751.80M | 807.44M |
| Gross Margin | 62.7% | 62.7% | 44.0% | 44.0% |
| Operating Margin | -20.8% | -18.7% | 20.9% | 23.7% |
| Profit Margin | -19.3% | -18.3% | 17.8% | 17.2% |
| Rev Growth | +58.3% | +58.3% | +21.7% | +17.2% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 5.03B | 5.03B | 4.60B | 4.62B |
| Total Equity | 1.99B | 1.99B | 6.78B | 7.47B |
| D/E Ratio | 2.52 | 2.52 | 0.68 | 0.62 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | -257,408,233 | -154,487,220 | 1.29B | 1.47B |
| Free Cash Flow | — | — | 351.34M | 441.08M |